Andy Miller's practice focuses on the interplay between litigation and regulatory issues affecting the health care industry. He has over 13 years' experience litigating complex, multiparty, multidistrict cases and proficiency navigating various regulatory issues, including FDA, ACA, 340B and HIPAA compliance.
Before rejoining the Firm, Andy was an attorney in the National Complex Litigation and Investigations Division of the U.S. Department of Health & Human Services, Office of the General Counsel, overseeing HHS's largest, most complex and high-profile cases across its litigation and regulatory portfolio. He was appointed by the HHS Secretary as one of only six individuals to serve as a panel member on the newly formed 340B Administrative Dispute Resolution Board to adjudicate disputes between covered entities and manufacturers. Andy was also a Special Attorney for the Commercial Litigation Branch, Civil Division of the U.S. Department of Justice.
Andy Miller's practice focuses on the interplay between litigation and regulatory issues affecting the health care industry. He has over 13 years' experience litigating complex, multiparty, multidistrict cases and proficiency navigating various regulatory issues, including FDA, ACA, 340B and HIPAA compliance.
Before rejoining the Firm, Andy was an attorney in the National Complex Litigation and Investigations Division of the U.S. Department of Health & Human Services, Office of the General Counsel, overseeing HHS's largest, most complex and high-profile cases across its litigation and regulatory portfolio. He was appointed by the HHS Secretary as one of only six individuals to serve as a panel member on the newly formed 340B Administrative Dispute Resolution Board to adjudicate disputes between covered entities and manufacturers. Andy was also a Special Attorney for the Commercial Litigation Branch, Civil Division of the U.S. Department of Justice.
Andy has extensive experience in litigating complex, multiparty cases and is well-versed in all pre-trial, trial and post-trial phases of federal court litigation. He has litigated several large-scale patent-infringement actions under the Hatch-Waxman Amendments to the Federal Food, Drug and Cosmetic Act for pharmaceutical products. He also counsels clients regarding regulatory compliance.
Andy also has represented clients in antitrust actions related to pharmaceutical products, including actions involving reverse payments, product hopping and REMS. During law school, he served as a research assistant for Professor Herbert Hovenkamp, a renowned expert in antitrust law.
Andy’s experience includes:
Government Experience
Patent Litigation
Antitrust Litigation